Cervical Dysplasia is abnormal growth of cells on the cervix. It is also referred as cervical intraepithelial neoplasia. Cervical Dysplasia can be cured before it becomes cancerous with the help of proper treatment and regular diagnosis. It is sexually transmitted disease which is caused due to HPV (Human Papillomavirus) Infection. Cervical dysplasia does not have any symptoms. It can diagnose by various diagnostic tests and devices.
Increases in government support, funding, and investment in number of countries on vaccination, social mobilization, screening, and community education is expected to propel the global cervical dysplasia market growth. Furthermore, rise in incidences of cancer patients across the globe which is expected to significantly influence the market growth. For instance, as per the WHO around 570,000 new cases of cervical cancer reported in year 2018. Also, continuous technological advancements such as cytology-based screening are another driving factor which expected to fuel the market growth in near future. Moreover, increase in research and development activities will drive the global cervical dysplasia market growth. The rise in population of women in the reproductive age is rising and this demand demands better awareness and better diagnostic tests which is expected to boost the market growth over the forecast period.
Lack of awareness regarding cervical dysplasia in emerging countries is expected to limit the global cervical dysplasia market growth. Majority of women in emerging countries still do not aware regarding cervical cancer screening tests and its early detection. Also, high cost required for research and development activities will hinder the market growth.
Global Cervical Dysplasia Market is segmented into product type such as Diagnostic Test, and Diagnostic Devices. Further market is segmented into end user such as Hospitals, Diagnostic Centers, Private Gynecologists Offices, Research & Academic Institutes, and Ambulatory Surgical Centers.
Also, Cervical Dysplasia Market is segmented five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are listed in this report Abbott Laboratories, QIAGEN N.V., F. Hoffmann La-Roche Ltd, OncoHealth Corporation, Quest Diagnostics, Inc., ASKA Pharmaceutical Co., Ltd., KinoPharma, Inc., BetterLife Pharma Inc, and Hologic, Inc.
By End User Hospitals Diagnostic Centers Private Gynecologists Offices Research & Academic Institutes Ambulatory Surgical Centers
By Region North America Latin America Europe Asia Pacific Middle East & Africa
Key Questions Addressed by the Report What are the Key Opportunities in Global Cervical Dysplasia Market? What will be the growth rate from 2019 to 2030? Which segment/region will have highest growth? What are the factors that will impact/drive the Market? What is the competitive Landscape in the Industry? What is the role of key players in the value chain? What are the strategies adopted by key players?
Global Cervical Dysplasia Market TOC
1 Introduction 1.1 Objective of the Study 1.2 Market definition 1.3 Market Scope
2 Research Methodology
2.1 Data Mining 2.2 Validation 2.3 Primary Interviews 2.4 List of Data Sources
3 Executive Summary 4 Global Cervical Dysplasia Market Outlook 4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis
5 Global Cervical Dysplasia Market, By Product Type 5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Cervical Dysplasia Market Share Analysis, By Product Type
5.3 Global Cervical Dysplasia Market Size and Forecast, By Product Type 5.3.1 Diagnostic Tests
5.3.2 Diagnostic Devices
6 Global Cervical Dysplasia Market, By End User 6.1 Y-o-Y Growth Comparison, By End User
6.2 Global Cervical Dysplasia Market Share Analysis, By End User
6.3 Global Cervical Dysplasia Market Size and Forecast, By End User 6.3.1 Hospitals 6.3.2 Diagnostic Centres
6.3.3 Private Gynaecologists Offices
6.3.4 Research & Academic Institutes
6.3.5 Ambulatory Surgical Centres
7Global Cervical Dysplasia Market, By Region 7.1 Global Cervical Dysplasia Market Share Analysis, By Region
7.2 Global Cervical Dysplasia Market Share Analysis, By Region
7.3 Global Cervical Dysplasia Market Size and Forecast, By Region
8North America Cervical Dysplasia Market Analysis and Forecast (2020 – 2030) 8.1 Introduction
8.2 North America Cervical Dysplasia Market Share Analysis, By Product Type
8.3 North America Cervical Dysplasia Market Size and Forecast, By End User
8.4 North America Cervical Dysplasia Market Size and Forecast, By Country
8.4.1 U.S 8.4.2 Canada 8.4.3 Mexico
9Europe Cervical Dysplasia Market Analysis and Forecast (2020 – 2030) 9.1 Introduction
9.2 Europe Cervical Dysplasia Market Share Analysis, By Product Type
9.3 Europe Cervical Dysplasia Market Size and Forecast, By End User
9.4 Europe Cervical Dysplasia Market Size and Forecast, By Country
9.4.1 Germany 9.4.2 France 9.4.3 UK
9.4.4. Rest of Europe
10Asia Pacific Cervical Dysplasia Market Analysis and Forecast (2020 – 2030) 10.1 Introduction
10.2 Asia Pacific Cervical Dysplasia Market Share Analysis, By Product Type
10.3 Asia Pacific Cervical Dysplasia Market Size and Forecast, By End User
10.4 Asia Pacific Cervical Dysplasia Market Size and Forecast, By Country
10.4.1 China 10.4.2 Japan 10.4.3 India
10.4.4. Rest of Asia Pacific
11Latin America Cervical Dysplasia Market Analysis and Forecast (2020 – 2030) 11.1 Introduction
11.2 Latin America Cervical Dysplasia Market Share Analysis, By Product Type
11.3 Latin America Cervical Dysplasia Market Size and Forecast, By End User
11.4 Latin America Cervical Dysplasia Market Size and Forecast, By Country
12Middle East Cervical Dysplasia Market Analysis and Forecast (2020 – 2030) 12.1 Introduction
12.2 Middle East Cervical Dysplasia Market Share Analysis, By Product Type
12.3 Middle East Cervical Dysplasia Market Size and Forecast, By End User
12.4 Middle East Cervical Dysplasia Market Size and Forecast, By Country
13Competitive Analysis 13.1 Competition Dashboard 13.2 Market share Analysis of Top Vendors 13.3 Key Development Strategies
14Company Profiles
14.1 Abbott Laboratories 14.1.1 Overview 14.1.2 Offerings 14.1.3 Key Financials 14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 QIAGEN N.V.
14.2.1 Overview 14.2.2 Offerings 14.2.3 Key Financials 14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 F. Hoffmann La-Roche Ltd
14.3.1 Overview 14.3.2 Offerings 14.3.3 Key Financials 14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 OncoHealth Corporation 14.4.1 Overview 14.4.2 Offerings 14.4.3 Key Financials 14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Quest Diagnostics, Inc 14.5.1 Overview 14.5.2 Offerings 14.5.3 Key Financials 14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 ASKA Pharmaceutical Co., Ltd 14.6.1 Overview 14.6.2 Offerings 14.6.3 Key Financials 14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 KinoPharma, Inc 14.7.1 Overview 14.7.2 Offerings 14.7.3 Key Financials 14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 BetterLife Pharma Inc
14.8.1 Overview 14.8.2 Offerings 14.8.3 Key Financials 14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 Hologic, Inc
14.9.1 Overview 14.9.2 Offerings 14.9.3 Key Financials 14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
